Pharm-Olam International Ltd., a multi-national, full-service clinical research solutions organization (CRO) to biopharmaceutical and device industries, has relocated its Polish location to a larger office to accommodate for its growing staff. “We have seen a significant increase in interest in running trials in Poland and we are expanding our offices to accommodate the current and future workload,” said Sanjiv Suri, chief executive officer, Pharm-Olam. “When we opened our first operating off...